PDS Biotechnology Net Income Over Time
| PDSB Stock | USD 0.71 0.01 0.94% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out PDS Biotechnology Performance and PDS Biotechnology Correlation. Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of PDS Biotechnology. Anticipated expansion of PDS directly elevates investor willingness to pay premium valuations. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive PDS Biotechnology assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Investors evaluate PDS Biotechnology Corp using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating PDS Biotechnology's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. External factors like market trends, sector rotation, and investor psychology can cause PDS Biotechnology's market price to deviate significantly from intrinsic value.
It's important to distinguish between PDS Biotechnology's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding PDS Biotechnology should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, PDS Biotechnology's market price signifies the transaction level at which participants voluntarily complete trades.
Cross Equities Net Income Analysis
Compare PDS Biotechnology Corp and related stocks such as Actinium Pharmaceuticals, Xilio Development, and LAVA Therapeutics Net Income Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ATNM | (18.4 K) | 10.3 K | (8.4 M) | (10.8 M) | (24.7 M) | (21 M) | (24.3 M) | (26.6 M) | (23.7 M) | (21.9 M) | (22.2 M) | (24.8 M) | (33 M) | (48.8 M) | (38.2 M) | (34.4 M) | (32.7 M) |
| XLO | (17.3 M) | (17.3 M) | (17.3 M) | (17.3 M) | (17.3 M) | (17.3 M) | (17.3 M) | (17.3 M) | (17.3 M) | (17.3 M) | (55.2 M) | (74.3 M) | (87.3 M) | (76.4 M) | (58.2 M) | (52.4 M) | (55 M) |
| OKUR | (19.5 M) | (19.5 M) | (19.5 M) | (19.5 M) | (19.5 M) | (19.5 M) | (19.5 M) | (19.5 M) | (19.5 M) | (19.5 M) | (19.5 M) | (39.8 M) | (29.5 M) | (35.3 M) | (52.7 M) | (47.4 M) | (49.8 M) |
| TPST | (2.7 M) | (2.7 M) | (13.5 M) | (29 M) | (49.5 M) | (73.2 M) | (82.3 M) | (84.6 M) | (27.2 M) | (44.6 M) | (19.1 M) | (28.3 M) | (35.7 M) | (29.5 M) | (41.8 M) | (37.7 M) | (39.5 M) |
| KZR | (9 M) | (9 M) | (9 M) | (9 M) | (9 M) | (9 M) | (9 M) | (8.5 M) | (23.2 M) | (31.5 M) | (39 M) | (54.6 M) | (65.3 M) | (101.9 M) | (83.7 M) | (75.4 M) | (71.6 M) |
| RVPH | (1.7 M) | (1.7 M) | (1.7 M) | (1.7 M) | (1.7 M) | (1.7 M) | (1.7 M) | (1.7 M) | (1.7 M) | (846.8 K) | (3.8 M) | (8.5 M) | (24.3 M) | (39.3 M) | (29.9 M) | (26.9 M) | (25.6 M) |
| ANVS | (369.6 K) | (4.7 M) | (8.3 M) | (682.3 K) | (682.3 K) | (682.3 K) | (682.3 K) | (682.3 K) | (713.9 K) | (991 K) | (5.5 M) | (14.5 M) | (25.1 M) | (56.2 M) | (24.6 M) | (22.1 M) | (21 M) |
| INMB | (48.9 K) | (48.9 K) | (48.9 K) | (48.9 K) | (48.9 K) | (48.9 K) | (277 K) | (831 K) | (12.4 M) | (7.7 M) | (12.1 M) | (30.3 M) | (28.6 M) | (30 M) | (42.1 M) | (37.9 M) | (36 M) |
PDS Biotechnology Corp and related stocks such as Actinium Pharmaceuticals, Xilio Development, and LAVA Therapeutics Net Income description
Net income is one of the most important fundamental items in finance. It plays a large role in PDS Biotechnology Corp financial statement analysis. It represents the amount of money remaining after all of PDS Biotechnology Corp operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.My Equities
My Current Equities and Potential Positions
| PDS Biotechnology Corp | PDSB |
| Classification | Biotech |
| Business Address | 303A College Road |
| Exchange | NASDAQ Exchange |
USD 0.7066
Check out PDS Biotechnology Performance and PDS Biotechnology Correlation. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.
PDS Biotechnology technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.